CD146
Cancer-associated fibroblast
Endometrial cancer
Interleukin 10
Vasculogenic mimicry
Journal
Cell communication and signaling : CCS
ISSN: 1478-811X
Titre abrégé: Cell Commun Signal
Pays: England
ID NLM: 101170464
Informations de publication
Date de publication:
08 Mar 2024
08 Mar 2024
Historique:
received:
16
12
2023
accepted:
01
03
2024
medline:
9
3
2024
pubmed:
9
3
2024
entrez:
8
3
2024
Statut:
epublish
Résumé
Heterogeneous cancer-associated fibroblasts (CAFs) play important roles in cancer progression. However, the specific biological functions and regulatory mechanisms involved in endometrial cancer have yet to be elucidated. We aimed to explore the potential mechanisms of heterogeneous CAFs in promoting endometrial cancer progression. The presence of melanoma cell adhesion molecule (MCAM; CD146) positive CAFs was confirmed by tissue multi-immunofluorescence (mIF), and fluorescence activated cell sorting (FACS). The biological functions were determined by wound healing assays, tuber formation assays and cord formation assays. The effects of CD146
Identifiants
pubmed: 38459564
doi: 10.1186/s12964-024-01550-9
pii: 10.1186/s12964-024-01550-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
170Subventions
Organisme : The National Natural Science Foundation of China
ID : 82211530457
Organisme : the International Science and technology cooperation project of Hubei Province
ID : GJHZ2021000024
Organisme : Natural Science Foundation of Hubei Province
ID : 2021CFB589
Informations de copyright
© 2024. The Author(s).
Références
Crosbie EJ, Kitson SJ, McAlpine JN, et al. Endometrial cancer. Lancet. 2022;399(10333):1412–28.
pubmed: 35397864
doi: 10.1016/S0140-6736(22)00323-3
Chen HX, Cleck JN. Adverse effects of anticancer agents that target the VEGF pathway. Nat Rev Clin Oncol. 2009;6(8):465–77.
pubmed: 19581909
doi: 10.1038/nrclinonc.2009.94
Higa GM, Abraham J. Biological mechanisms of bevacizumab-associated adverse events. Expert Rev Anticancer Ther. 2009;9(7):999–1007.
pubmed: 19589038
doi: 10.1586/era.09.68
Li T, Kang G, Wang T, et al. Tumor angiogenesis and anti-angiogenic gene therapy for cancer. Oncol Lett. 2018;16(1):687–702.
pubmed: 29963134
pmcid: 6019900
Herrera-Vargas AK, Garcia-Rodriguez E, Olea-Flores M, et al. Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer. Cytokine Growth Factor Rev. 2021;62:23–41.
pubmed: 34736827
doi: 10.1016/j.cytogfr.2021.10.006
Abu-Rustum NR, Yashar CM, Bradley K, et al. NCCN guidelines(R) insights: uterine neoplasms, version 3.2021. J Natl Compr Canc Netw. 2021;19(8):888–95.
pubmed: 34416706
doi: 10.6004/jnccn.2021.0038
Luo Q, Wang J, Zhao W, et al. Vasculogenic mimicry in carcinogenesis and clinical applications. J Hematol Oncol. 2020;13(1):19.
pubmed: 32169087
pmcid: 7071697
doi: 10.1186/s13045-020-00858-6
Wei X, Chen Y, Jiang X, et al. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Mol Cancer. 2021;20(1):7.
pubmed: 33397409
pmcid: 7784348
doi: 10.1186/s12943-020-01288-1
Delgado-Bellido D, Serrano-Saenz S, Fernandez-Cortes M, et al. Vasculogenic mimicry signaling revisited: focus on non-vascular VE-cadherin. Mol Cancer. 2017;16(1):65.
pubmed: 28320399
pmcid: 5359927
doi: 10.1186/s12943-017-0631-x
Hendrix MJ, Seftor EA, Meltzer PS, et al. Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry. Proc Natl Acad Sci U S A. 2001;98(14):8018–23.
pubmed: 11416160
pmcid: 35460
doi: 10.1073/pnas.131209798
Xie J, Kong X, Wang W, et al. Vasculogenic mimicry formation predicts tumor progression in oligodendroglioma. Pathol Oncol Res. 2021;27:1609844.
pubmed: 34483751
pmcid: 8408314
doi: 10.3389/pore.2021.1609844
Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.
pubmed: 33259885
doi: 10.1016/j.pharmthera.2020.107753
Biffi G, Tuveson DA. Diversity and biology of cancer-associated fibroblasts. Physiol Rev. 2021;101(1):147–76.
pubmed: 32466724
doi: 10.1152/physrev.00048.2019
Mao X, Xu J, Wang W, et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131.
pubmed: 34635121
pmcid: 8504100
doi: 10.1186/s12943-021-01428-1
Verginadis II, Avgousti H, Monslow J, et al. A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nat Cell Biol. 2022;24(6):940–53.
pubmed: 35654839
pmcid: 9203279
doi: 10.1038/s41556-022-00918-8
Yu Z, Zhang J, Zhang Q, et al. Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. Cell Prolif. 2022;55(6):e13249.
pubmed: 35560676
pmcid: 9201371
doi: 10.1111/cpr.13249
Alagem N, Dvir M, Reuveny E. Mechanism of Ba(2+) block of a mouse inwardly rectifying K+ channel: differential contribution by two discrete residues. J Physiol. 2001;534(Pt. 2):381–93.
pubmed: 11454958
pmcid: 2278702
doi: 10.1111/j.1469-7793.2001.00381.x
Allred DC, Harvey JM, Berardo M, et al. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol. 1998;11(2):155–68.
pubmed: 9504686
Mannino MH, Zhu Z, Xiao H, et al. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015;367(2):103–7.
pubmed: 26188281
doi: 10.1016/j.canlet.2015.07.009
Rallis KS, Corrigan AE, Dadah H, et al. IL-10 in cancer: an essential thermostatic regulator between homeostatic immunity and inflammation - a comprehensive review. Future Oncol. 2022;18(29):3349–65.
pubmed: 36172856
doi: 10.2217/fon-2022-0063
Wang M, Zhao X, Zhu D, et al. HIF-1alpha promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment. J Exp Clin Cancer Res. 2017;36(1):60.
pubmed: 28449718
pmcid: 5408450
doi: 10.1186/s13046-017-0533-1
Zhao B, Wu M, Hu Z, et al. Thrombin is a therapeutic target for non-small-cell lung cancer to inhibit vasculogenic mimicry formation. Signal Transduct Target Ther. 2020;5(1):117.
pubmed: 32647187
pmcid: 7347850
doi: 10.1038/s41392-020-0167-1
Cao Z, Bao M, Miele L, et al. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis. Eur J Cancer. 2013;49(18):3914–23.
pubmed: 23992642
doi: 10.1016/j.ejca.2013.07.148
Vartanian AA, Burova OS, Stepanova EV, et al. Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level. Melanoma Res. 2007;17(6):370–9.
pubmed: 17992120
doi: 10.1097/CMR.0b013e3282f1d2ec
Xie HJ, Zhao J, Zhuo-Ma D, et al. Inhibiting tumour metastasis by DQA modified paclitaxel plus ligustrazine micelles in treatment of non-small-cell lung cancer. Artif Cells Nanomed Biotechnol. 2019;47(1):3465–77.
pubmed: 31432702
doi: 10.1080/21691401.2019.1653900
Li X, Yang Z, Han Z, et al. Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3. Oncol Rep. 2018;39(2):827–33.
pubmed: 29251334
Chen YS, Chen ZP. Vasculogenic mimicry: a novel target for glioma therapy. Chin J Cancer. 2014;33(2):74–9.
pubmed: 23816560
pmcid: 3935008
doi: 10.5732/cjc.012.10292
Wang FT, Sun W, Zhang JT, et al. Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer. Oncol Lett. 2019;17(3):3055–65.
pubmed: 30867734
pmcid: 6396119
Pan MS, Wang H, Ansari KH, et al. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway. J Exp Clin Cancer Res. 2020;39(1):234.
pubmed: 33153467
pmcid: 7643415
doi: 10.1186/s13046-020-01742-4
Kim HS, Won YJ, Shim JH, et al. Role of EphA2-PI3K signaling in vasculogenic mimicry induced by cancer-associated fibroblasts in gastric cancer cells. Oncol Lett. 2019;18(3):3031–8.
pubmed: 31452781
pmcid: 6704280
Ding X, Xi W, Ji J, et al. HGF derived from cancer-associated fibroblasts promotes vascularization in gastric cancer via PI3K/AKT and ERK1/2 signaling. Oncol Rep. 2018;40(2):1185–95.
pubmed: 29917165
She Q, Hu S, Pu X, et al. The effect of hepatocellular carcinoma-associated fibroblasts on hepatoma vasculogenic mimicry. Am J Cancer Res. 2020;10(12):4198–210.
pubmed: 33414995
pmcid: 7783763
Wang Z, Xu Q, Zhang N, et al. CD146, from a melanoma cell adhesion molecule to a signaling receptor. Signal Transduct Target Ther. 2020;5(1):148.
pubmed: 32782280
pmcid: 7421905
doi: 10.1038/s41392-020-00259-8
Kobayashi H, Gieniec KA, Lannagan TRM, et al. The origin and contribution of cancer-associated fibroblasts in colorectal carcinogenesis. Gastroenterology. 2022;162(3):890–906.
pubmed: 34883119
doi: 10.1053/j.gastro.2021.11.037
Zhang M, Yang H, Wan L, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol. 2020;73(5):1118–30.
pubmed: 32505533
doi: 10.1016/j.jhep.2020.05.039
Januszyk P, Januszyk K, Wierzbik-Strońska M, et al. Analysis of the differences in the expression of mRNAs and miRNAs associated with drug resistance in endometrial cancer cells treated with salinomycin. Curr Pharm Biotechnol. 2021;22(4):541–8.
pubmed: 32598254
doi: 10.2174/1389201021666200629151008
Abdelmaksoud NM, El-Mahdy HA, Ismail A, et al. The role of miRNAs in the pathogenesis and therapeutic resistance of endometrial cancer: a spotlight on the convergence of signaling pathways. Pathol Res Pract. 2023;244:154411.
pubmed: 36921547
doi: 10.1016/j.prp.2023.154411
Short WD, Steen E, Kaul A, et al. IL-10 promotes endothelial progenitor cell infiltration and wound healing via STAT3. FASEB J. 2022;36(7):e22298.
pubmed: 35670763
doi: 10.1096/fj.201901024RR
Suen JL, Chang Y, Shiu YS, et al. IL-10 from plasmacytoid dendritic cells promotes angiogenesis in the early stage of endometriosis. J Pathol. 2019;249(4):485–97.
pubmed: 31418859
pmcid: 6899974
doi: 10.1002/path.5339
Zeng L, O’Connor C, Zhang J, et al. IL-10 promotes resistance to apoptosis and metastatic potential in lung tumor cell lines. Cytokine. 2010;49(3):294–302.
pubmed: 20034810
doi: 10.1016/j.cyto.2009.11.015
Kohno T, Mizukami H, Suzuki M, et al. Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res. 2003;63(16):5091–4.
pubmed: 12941839